| March 5, 2013 | News for the transfusion medicine and cellular therapy community |
 |  |
- High-speed cameras show blood plasma's elastic qualities
Scientists at Saarland University in Germany used high-speed cameras to find that blood plasma can behave like a solid at small scales, according to a study in the journal Physical Review Letters. Thanks to long molecules contained in plasma, the solution has properties that are both viscous and elastic, allowing an elongated flow through tight capillaries or past clots. Researchers said their work could lead to improved models of blood flow and help advance the development of artificial blood. InsideScience.org
(3/1)     
|
|
Want More CME/CE Credit from AABB?
Now it's even easier to accomplish your training needs and earn CME/CE credits. Convenient and accessible anytime, the AABB Live Learning Center offers quick access to essential Annual Meeting and audioconference content. Most products offer CME/CE tracking and attendance certification. Click here to get started! |
| Science & Health |  |  |
|
- 22 patient safety measures backed by AHRQ
The Agency for Healthcare Research and Quality has issued 10 strategies for improving patient safety that should be adopted immediately and an additional 12 strategies that are encouraged. Among those strongly recommended for immediate use are preoperative and anesthesia checklists, hand hygiene and interventions for reducing urinary catheter use. The strategies were published in the Annals of Internal Medicine. DoctorsLounge.com/HealthDay News
(3/4)
| Emerging Trends | | |
|
- Report IDs 6 primary areas of focus for ACO metrics
A report by MedeAnalytics found that accountable care organization metrics fall into six major categories including pediatric, ambulatory and acute care. Researchers also report that commercial ACOs were more likely to focus on ambulatory processes and cost reduction, while Medicare ACOs were more focused on quality outcomes. BeckersHospitalReview.com
(3/4)
| Industry News & Practice | | |
|
| Government & Regulatory | | |
|
- FDA accepts Biogen Idec's hemophilia B drug for review
The FDA has set a timeline to review Biogen Idec's biologics license application for its recombinant factor IX Fc fusion protein as a therapy for patients with hemophilia B. The drug is among a new class of long-lasting clotting factor therapies in the pipeline for hemophilia B. Boston Herald
(3/4)
 |
|  |
| The Buzz(CORPORATE ANNOUNCEMENTS)
A Clear Path to ISBT 128 CT
Stop being confused about ISBT 128 for Cell Therapy and turn to the experts for the solutions you deserve. Learn how HemaTrax®-CT and StemLab™ can help you adopt ISBT quickly and easily in an industry-standard solution that will save you time and increase efficiency and quality in your facility. Contact us to learn more now.
| |
 |
|  |
| Association News | | |
|
-
ISQua grants AABB continued accreditation
The AABB Accreditation Program has been granted continued accreditation by the International Society for Quality in Health Care, or ISQua. This second, four-year accreditation award is granted for January 2013 through December 2016. More information is available online.
| SmartQuote | | |
|
 | Concentrate all your thoughts upon the work at hand. The sun's rays do not burn until brought to a focus."
--Alexander Graham Bell,
Scottish-born American inventor
|
| |
| |
|
Read more at SmartBrief.com |
|
A powerful website for SmartBrief readers including:
|
|
|
|
| |
| |
| | Recent AABB SmartBrief Issues:
- Monday, March 04, 2013
- Friday, March 01, 2013
- Thursday, February 28, 2013
- Wednesday, February 27, 2013
- Tuesday, February 26, 2013
| | | Lead Editor: Tom Parks
Managing Editor: Jennifer Garfinkel
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | |
| |
|
| © 1999-2013 SmartBrief, Inc.® Legal Information |
|
